Biotin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00121 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | dyspepsia | KG + DL |
| 2 | gastroparesis (disease) | KG + DL |
| 3 | mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies | KG + DL |
| 4 | familial visceral myopathy | KG + DL |
| 5 | anemia of prematurity | KG + DL |
| 6 | congenital prothrombin deficiency | KG + DL |
| 7 | vitamin deficiency disorder | KG + DL |
| 8 | biotin metabolic disease | KG + DL |
| 9 | cystinosis | KG + DL |
| 10 | obsolete contact dermatitis caused by poison oak | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.